Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study

Fig. 5

PDFF difference (SD) per SD change in amino acids. PDFF measured in the UKB was used as a continuous outcome proxying for MAFLD to validate the primary MR analysis results. CI, confidence intervals; IV, instrumental variable; IVW, inverse variance weighted; MR, Mendelian randomization; P, p value; PDFF, proton density fat fraction; SD, standard deviation; UKB, UK Biobank

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us